| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | — |
| Cost of Revenue | $296K | — |
| R&D Expense | $5.5M | -61.1% |
| SG&A Expense | $8.8M | -4.3% |
| Operating Income | -$13.6M | +42.2% |
| Pre-tax Income | -$13.5M | -234.2% |
| Income Tax | $0 | — |
| Net Income | -$13.4M | -230.6% |
| EPS (Basic) | -$1.20 | -150.0% |
| EPS (Diluted) | -$1.20 | -150.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.7M | +57.4% |
| Current Assets | $27.1M | +46.7% |
| Total Assets | $32.5M | +46.9% |
| Current Liabilities | $23.7M | +9.6% |
| Total Liabilities | $29.6M | +5.4% |
| Stockholders' Equity | $2.8M | +147.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.9M | -283.3% |
| Capital Expenditures | $385K | -32.8% |
| Investing Cash Flow | -$385K | +32.8% |
| Financing Cash Flow | $19.3M | +4343.5% |
| Free Cash Flow | -$10.3M | -313.0% |